Canquan Mao

826 total citations
43 papers, 606 citations indexed

About

Canquan Mao is a scholar working on Molecular Biology, Oncology and Immunology. According to data from OpenAlex, Canquan Mao has authored 43 papers receiving a total of 606 indexed citations (citations by other indexed papers that have themselves been cited), including 29 papers in Molecular Biology, 7 papers in Oncology and 7 papers in Immunology. Recurrent topics in Canquan Mao's work include Peptidase Inhibition and Analysis (4 papers), FOXO transcription factor regulation (4 papers) and Extracellular vesicles in disease (4 papers). Canquan Mao is often cited by papers focused on Peptidase Inhibition and Analysis (4 papers), FOXO transcription factor regulation (4 papers) and Extracellular vesicles in disease (4 papers). Canquan Mao collaborates with scholars based in China, Canada and Australia. Canquan Mao's co-authors include Wensheng Qin, Miranda Maki, Mehdi Dashtban, Kam Tin Leung, Yuhong Jiang, Xiujuan Fu, Xin Zhuo, Lili Xiong, Zhiyun Guo and Shuquan Rao and has published in prestigious journals such as ACS Nano, PLoS ONE and Scientific Reports.

In The Last Decade

Canquan Mao

41 papers receiving 589 citations

Peers

Countries citing papers authored by Canquan Mao

Since Specialization

Citations

This map shows the geographic impact of Canquan Mao's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Canquan Mao with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Canquan Mao more than expected).

Fields of papers citing papers by Canquan Mao

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Canquan Mao. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Canquan Mao. The network helps show where Canquan Mao may publish in the future.

Co-authorship network of co-authors of Canquan Mao

This figure shows the co-authorship network connecting the top 25 collaborators of Canquan Mao. A scholar is included among the top collaborators of Canquan Mao based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Canquan Mao. Canquan Mao is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Polysaccharide nanoparticles as potential immune adjuvants: Mechanism and function 2025 ·Acta Pharmaceutica Sinica B ·Yuhong Jiang, Shanshan Qi, Canquan Mao	9
2	A novel designed fully peptide-based PROTAC, FPP29, demonstrates its potent cytotoxic effects to liver cancer HCCLM3 cells by targeting FOXM1 2025 ·Bioorganic Chemistry ·(unknown), Hui Qi, (unknown), (unknown), (unknown), (unknown), Dingyu Wu, Yuhong Jiang, Xinrong Liu, Canquan Mao	2
3	Manganese oxide nanoparticle acts as a promising immune adjuvant via tuning ferroptosis signaling 2025 ·Journal of Controlled Release ·Xiaoyu Liang, Shanshan Qi, Fang Lü, Yue Wu, Canquan Mao, Yuhong Jiang	2
4	Dissecting the multi-omics landscape of TEAD1 in hepatocellular carcinoma: cycle regulation and metastatic potential 2025 ·Frontiers in Immunology ·(unknown), Canquan Mao, Lili Xiong	0
5	Dual‐functional Nanosized Albumin Facilitates CRISPR‐Cas9‐PAR2 to Mitigate Cytokine Storm via TLR4 and Pyroptosis Signaling 2024 ·Small ·Jianbin Li, Dongmei Zheng, Shanshan Qi, Canquan Mao, Yuhong Jiang	3
6	Interplay between G protein-coupled receptors and nanotechnology 2023 ·Acta Biomaterialia ·Yuhong Jiang, Yuke Li, Xiujuan Fu, Yue Wu, Rujing Wang, Mengnan Zhao, Canquan Mao, Sanjun Shi	11
7	Genome editing of PAR2 through targeted delivery of CRISPR-Cas9 system for alleviating acute lung inflammation via ERK/NLRP3/IL-1β and NO/iNOS signalling 2023 ·Acta Pharmaceutica Sinica B ·Xin Zhuo, Yue Wu, Xiujuan Fu, Jianbin Li, (unknown), Xiaoyu Liang, Canquan Mao, Yuhong Jiang	6
8	PAR2 blockade reverses osimertinib resistance in non-small-cell lung cancer cells via attenuating ERK-mediated EMT and PD-L1 expression 2021 ·Biochimica et Biophysica Acta (BBA) - Molecular Cell Research ·Yuhong Jiang, Xin Zhuo, Yue Wu, Xiujuan Fu, Canquan Mao	24
9	Targeting PAR2 Overcomes Gefitinib Resistance in Non-Small-Cell Lung Cancer Cells Through Inhibition of EGFR Transactivation 2021 ·Frontiers in Pharmacology ·Yuhong Jiang, Xin Zhuo, Xiujuan Fu, Yue Wu, Canquan Mao	22
10	PAMs inhibits monoamine oxidase a activity and reduces glioma tumor growth, a potential adjuvant treatment for glioma 2020 ·BMC Complementary Medicine and Therapies ·(unknown), Shih-Yi Chen, (unknown), Canquan Mao, (unknown), Jean C. Shih	10
11	Down-regulation expression of TGFB2-AS1 inhibits the proliferation, migration, invasion and induces apoptosis in HepG2 cells 2019 ·Genes & Genomics ·Wenrong Liu, (unknown), Yin Zhang, Shuquan Rao, Lili Xiong, Ruofan Ding, Canquan Mao, Wenqing Zhao, Tao Hao, Qingqing Huang, Zhiyun Guo	7
12	An APOE -independent cis -eSNP on chromosome 19q13.32 influences tau levels and late-onset Alzheimer's disease risk 2018 ·Neurobiology of Aging ·Shuquan Rao, Mahdi Ghani, Zhiyun Guo, Yuetiva Deming, Kesheng Wang, Rebecca Sims, Canquan Mao, Yao Yao, Carlos Cruchaga, Dietrich Stephan, Ekaterina Rogaeva	14
13	Transcriptome profiling analysis of differentially expressed mRNAs and lncRNAs in HepG2 cells treated with peptide 9R-P201 2017 ·Biotechnology Letters ·Wenrong Liu, Ruofan Ding, Yiming Zhang, Canquan Mao, Ran Kang, (unknown), Qingqing Huang, Lili Xiong, Zhiyun Guo	6
14	Genetic association of rs1344706 in ZNF804A with bipolar disorder and schizophrenia susceptibility in Chinese populations 2017 ·Scientific Reports ·Shuquan Rao, Yao Yao, Joanne Ryan, Chunhui Jin, Yong Xu, Xinhe Huang, (unknown), Yueqiang Wen, Canquan Mao, David Meyre, Fuquan Zhang	12
15	PAMs ameliorates the imiquimod-induced psoriasis-like skin disease in mice by inhibition of translocation of NF-κB and production of inflammatory cytokines 2017 ·PLoS ONE ·(unknown), Zongying Liu, Yuan Xue, (unknown), Ruixue Bai, Zhenfei Bi, (unknown), Yalan Yang, (unknown), Wei Su, Diqiang Li, Canquan Mao	25
16	The ACEII recombinant Trichoderma reesei QM9414 strains with enhanced xylanase production and its applications in production of xylitol from tree barks 2016 ·Microbial Cell Factories ·Lili Xiong, Ayyappa Kumar Sista Kameshwar, Xi Chen, Zhiyun Guo, Canquan Mao, Sanfeng Chen, Wensheng Qin	16
17	Bioinformatics Analysis of Plant Metallothionein MT2 2009 ·Canquan Mao	1
18	Optimization of solid state fermentation of Aspergillus Oryzae 3042 producing aminoacylase 2008 ·Science and Technology of Food Industry ·Tao Meng, (unknown), (unknown), Canquan Mao	1
19	A conformation-constrained peptide library based on insect defensin A 2004 ·Peptides ·An Zhao, (unknown), (unknown), Bo Gao, Jiannan Feng, Canquan Mao, Zheng Li, Nongle Liu, Jinpeng Wang, Hui‐Xin Wang	6
20	Progress of microbial display technology in the bioremediation of heavy metals 2001 ·Canquan Mao, (unknown), (unknown)	2

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact